Thank You for reading

Need a Covid-19 break? We have just posted a new story

• In a world's first, Locus Biosciences has enrolled the first patients in a clinical trial using bacteriophage boosted with CRISPR to cure urinary tract infections. The completely new antibacterial principle for curing disease comes as multi-drug resistance is on the rise.

In case You missed it

• A cure for cystic fibrosis? Dutch scientists use CRISPR base editors to cure cystic fibrosis in mini-organs derived from patient stem cells.
• Interview with Marcello Maresca, associate director at AstraZeneca, on CRISPR in vivo genome editing with no detectable off-target mutations.

Thank You for now - more great reads are on the way.

And if you have questions or suggestions, you can directly reach us at editor@crisprmedicinenews.com. We love hearing from readers!

(c; Rasmus

You can follow the blog on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up yourself here.